New York University · Biomedical EngineeringSulman Lab
Erik Sulman · New York, New York
Research Focus
Dr. Erik Sulman's research lab focuses on understanding and overcoming radiation resistance in glioblastoma, a severe type of brain cancer. By exploring how glioblastoma stem-like cells change states, the lab aims to find new ways to make these cancer cells more sensitive to radiation therapy. The research combines advanced genetic techniques with clinical data to develop better treatment strategies for patients suffering from this challenging disease.
glioblastomaradiation resistancecancer therapystem cellsgenomic analysisCRISPRmetabolic reprogrammingchromatin remodelingneuronal differentiation
Research Aims
3AIM 01Investigate the role of NANP inhibition in radiosensitizing glioblastoma cells through metabolic changes.
AIM 02Assess the impact of targeting HMGB2 on switching cell states and its lethal effects with radiation.
AIM 03Evaluate the effects of neuronal differentiation combined with TAZ inhibitors for enhancing radiosensitivity in GBM.
Skills the Lab Values
CRISPR screeningmass spectrometrycell culturemouse modelsgene expression analysisDNA repair assaysradiation therapy techniquesepigenetic profilingchemical inhibitor testing
Output against the department
Publications662top 9% of dept.56th of 595
this lab
most publishedleast published
Citations33ktop 8% of dept.45th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.